Sergei Viazov
Overview
Explore the profile of Sergei Viazov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Touni I, Tabll A, Sobieh S, Hewedy M, El Abd Y, Viazov S
Clin Lab
. 2017 Apr;
63(4):669-678.
PMID: 28397481
Background: Hepatitis C virus (HCV) is a major cause of liver disease worldwide and in Egypt. The aim of this study was to detect HCV E1/E2 antigens using a novel...
2.
Ross R, Wolters B, Hoffmann B, Geue L, Viazov S, Gruner N, et al.
Int J Med Microbiol
. 2015 Sep;
305(7):636-43.
PMID: 26384867
In 2005, six patients in Germany received solid organs and both corneas from a donor with an unrecognized rabies infection. Initial virological diagnostics with the machinery available at the two...
3.
Lange M, Fiedler M, Bankwitz D, Osburn W, Viazov S, Brovko O, et al.
PLoS One
. 2014 Jul;
9(7):e102235.
PMID: 25014219
Hepatitis C virus (HCV) infection is still a serious global health burden. Despite improved therapeutic options, a preventative vaccine would be desirable especially in undeveloped countries. Traditionally, highly conserved epitopes...
4.
Tabll A, El Abd Y, Bader El Din N, El Shenawy R, Abdelhafez T, El Awady M, et al.
Hum Antibodies
. 2014 Jun;
22(3-4):55-65.
PMID: 24961863
We aimed to establish Human cell lines producing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus (HCV). Two protocols for EBV immortalization of CD22⁺ cells separated...
5.
Lipskoch M, Wiese M, Timm J, Roggendorf M, Viazov S
Virol J
. 2014 Mar;
11:50.
PMID: 24628791
Background: No information is available on the possible influence of the genetic heterogeneity of major hepatitis C virus (HCV) cell receptors on selection of virus variants. Findings: Anti-D globulin preparations...
6.
Nitschke K, Barriga A, Schmidt J, Timm J, Viazov S, Kuntzen T, et al.
J Hepatol
. 2013 Aug;
60(1):22-9.
PMID: 23978718
Background & Aims: HLA-B*27 is associated with spontaneous HCV genotype 1 clearance. HLA-B*27-restricted CD8+ T cells target three NS5B epitopes. Two of these epitopes are dominantly targeted in the majority...
7.
Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, et al.
J Hepatol
. 2012 Oct;
58(2):234-9.
PMID: 23085648
Background & Aims: The progression of liver fibrosis in patients with chronic hepatitis C (CHC) is important to decide on the treatment of the virus. As liver biopsy and liver...
8.
Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang D, et al.
Gastroenterology
. 2011 Mar;
140(7):2064-73.
PMID: 21376049
Background & Aims: Hepatitis C virus (HCV) acquires mutations that allow it to escape the CD8+ T-cell response, although the extent to which this process contributes to viral evolution at...
9.
Uhde-Holzem K, Schlosser V, Viazov S, Fischer R, Commandeur U
J Virol Methods
. 2010 Feb;
166(1-2):12-20.
PMID: 20138085
The immunogenic properties of chimeric potato virus X (PVX) particles engineered to display the synthetic R9 peptide have been evaluated. The R9 peptide is a consensus sequence derived from diverse...
10.
Viazov S, Ross S, Kyuregyan K, Timm J, Neumann-Haefelin C, Isaeva O, et al.
J Med Virol
. 2009 Dec;
82(2):232-8.
PMID: 20029799
Systematic studies of the circulation of hepatitis C virus (HCV) recombinants in different parts of the world have been initiated only recently, and no detailed information on this subject is...